WILSON TROY EDWARD (CIK 1589597) reported 23 SEC Form 4 insider transactions across 4 companies over the past 18 months (most recent 2026-03-25). Recent activity: Buy KURA (6,103 shares), Sell RNAM (65,091 shares), Sell RNAM (13,711 shares), Buy KURA (182,500 shares), Buy KURA (182,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-25 | Kura Oncology, Inc. (KURA) | President and CEO | Buy | 6,103 | $37,533 |
| 2026-02-27 | Avidity Biosciences, Inc. (RNAM) | Director | Sell | 65,091 | $0 |
| 2026-02-27 | Avidity Biosciences, Inc. (RNAM) | Director | Sell | 13,711 | $0 |
| 2025-11-14 | Kura Oncology, Inc. (KURA) | President and CEO | Buy | 182,500 | $0 |
| 2025-09-29 | Kura Oncology, Inc. (KURA) | President and CEO | Buy | 182,500 | $0 |
| 2025-09-29 | Kura Oncology, Inc. (KURA) | President and CEO | Sell | 36,615 | $327,338 |
| 2025-09-09 | Kura Oncology, Inc. (KURA) | President & CEO | Buy | 50,000 | $410,000 |
| 2025-09-09 | Avidity Biosciences, Inc. (RNA) | Director | Buy | 14,500 | $180,960 |
| 2025-09-09 | Avidity Biosciences, Inc. (RNA) | Director | Sell | 14,500 | $725,000 |
| 2025-09-09 | Avidity Biosciences, Inc. (RNA) | Director | Sell | 15,000 | $750,000 |
| 2025-08-14 | Kura Oncology, Inc. (KURA) | President and CEO | Buy | 36,506 | $213,560 |
| 2025-08-14 | Kura Oncology, Inc. (KURA) | President and CEO | Buy | 13,494 | $89,600 |
| 2025-08-08 | Avidity Biosciences, Inc. (RNA) | Director | Buy | 22,000 | $264,660 |
| 2025-08-08 | Avidity Biosciences, Inc. (RNA) | Director | Sell | 22,000 | $990,000 |
| 2025-08-08 | Avidity Biosciences, Inc. (RNA) | Director | Buy | 7,500 | $93,600 |
| 2025-08-08 | Avidity Biosciences, Inc. (RNA) | Director | Sell | 7,500 | $337,500 |
| 2025-08-08 | Avidity Biosciences, Inc. (RNA) | Director | Sell | 15,000 | $675,000 |
| 2025-08-08 | Avidity Biosciences, Inc. (RNA) | Director | Sell | 15,000 | $675,000 |
| 2025-08-08 | Avidity Biosciences, Inc. (RNA) | Director | Sell | 17,777 | $799,965 |
| 2025-08-08 | Avidity Biosciences, Inc. (RNA) | Director | Sell | 17,777 | $799,965 |
| 2025-06-17 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Director | Sell | 10,800 | $36,720 |
| 2025-06-13 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Director | Buy | 27,000 | $0 |
| 2025-06-12 | Avidity Biosciences, Inc. (RNA) | Director | Buy | 6,692 | $0 |
Source: SEC Form 4 filings · as of 2026-03-25